Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.48 USD | -1.56% | +19.10% | +14.08% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.08% | 559M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.16% | 22.25B | |
-14.77% | 21.68B | |
-8.77% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Transcript : IGM Biosciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11